News

Medicines used to treat the rarest of illnesses made up the most expensive prescriptions of 2017. With costs approaching $800,000 per treatment, “orphan drugs” so named because they are used to treat these rare orphan illnesses, are bankrupting patients and their families. What can be done to make these critically important drugs more affordable for those who need it most?

We are writing to inform you that we have added the following three drugs to the QTdrugs lists.

The American opioid epidemic continues to affect millions of Americans every day. What are some of the factors that have led to the current situation, and what can you do to help the fight against this growing problem?

CredibleMeds can now inform users when the FDA label for drugs marketed in the US includes a recommendation for prescreening ECGs,...

We have added the following three drugs to the Possible Risk (PR) of TdP category due to evidence that they are associated with QT prolongation when taken at clinically recommended doses.

We’re pleased to announce that CredibleMeds was recently cited in two major scientific publications of practice guidelines for cardiologists.

QTdrugs lists now can be filtered by market status in US vs non-US

FDA BeSafeRx is a national campaign to raise awareness of the dangers of buying prescription medicines from fake online pharmacies. This campaign provides the resources to help consumers.

The CredibleMeds online QTdrugs list was recently applied in a study carried out in Denmark to evaluate the association between use of medications on sudden cardiac death (SCD). With a sharp increase in the number of prescribed drugs to the general population over the past decade, researchers sought to examine whether there is a significant correlation between multiple prescription drug use and SCD.

AZCERT, sponsor of CredibleMeds, is delighted to announce the addition of two new members to our Board of Directors. Doctors Jim Galloway and Jim Tisdale bring talent and broad expertise to the Board of AZCERT and CredibleMeds. For more information on the extraordinary stories of our newest leaders.